

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.11953754 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.11953754 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.92785912 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.99477402 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.59845432 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.59845432 |
| 7 | cellular response to type I interferon (GO:0071357) | 4.44358857 |
| 8 | type I interferon signaling pathway (GO:0060337) | 4.44358857 |
| 9 | response to type I interferon (GO:0034340) | 4.44219418 |
| 10 | response to interferon-beta (GO:0035456) | 4.29200736 |
| 11 | positive thymic T cell selection (GO:0045059) | 4.27676720 |
| 12 | cellular response to interferon-beta (GO:0035458) | 4.19388006 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 4.12208199 |
| 14 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.08602050 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.08586202 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 3.98393393 |
| 17 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.86789657 |
| 18 | positive regulation of antigen processing and presentation (GO:0002579) | 3.76417010 |
| 19 | detection of bacterium (GO:0016045) | 3.75151806 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 3.68893884 |
| 21 | detection of other organism (GO:0098543) | 3.61590686 |
| 22 | positive T cell selection (GO:0043368) | 3.52607604 |
| 23 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.50458756 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 3.49989126 |
| 25 | cellular response to zinc ion (GO:0071294) | 3.49447048 |
| 26 | cytidine deamination (GO:0009972) | 3.48143161 |
| 27 | cytidine metabolic process (GO:0046087) | 3.48143161 |
| 28 | cytidine catabolic process (GO:0006216) | 3.48143161 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 3.46376422 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.40976638 |
| 31 | defense response to protozoan (GO:0042832) | 3.40355202 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 3.40037511 |
| 33 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.39520571 |
| 34 | B cell mediated immunity (GO:0019724) | 3.38362197 |
| 35 | regulation of antigen processing and presentation (GO:0002577) | 3.33884969 |
| 36 | DNA deamination (GO:0045006) | 3.33871222 |
| 37 | response to interferon-alpha (GO:0035455) | 3.31933523 |
| 38 | respiratory burst (GO:0045730) | 3.28143250 |
| 39 | NIK/NF-kappaB signaling (GO:0038061) | 3.27303983 |
| 40 | viral transcription (GO:0019083) | 3.19992911 |
| 41 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19871647 |
| 42 | myeloid dendritic cell activation (GO:0001773) | 3.18906353 |
| 43 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.17321467 |
| 44 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.16338354 |
| 45 | thymic T cell selection (GO:0045061) | 3.16171541 |
| 46 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.14931317 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14318895 |
| 48 | cellular response to interleukin-15 (GO:0071350) | 3.14054220 |
| 49 | cellular response to exogenous dsRNA (GO:0071360) | 3.12625017 |
| 50 | T cell migration (GO:0072678) | 3.12360000 |
| 51 | T cell selection (GO:0045058) | 3.09300289 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08855202 |
| 53 | negative regulation of viral genome replication (GO:0045071) | 3.08749529 |
| 54 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.08658077 |
| 55 | response to peptidoglycan (GO:0032494) | 3.08102589 |
| 56 | response to protozoan (GO:0001562) | 3.07549267 |
| 57 | mature B cell differentiation involved in immune response (GO:0002313) | 3.06349048 |
| 58 | response to interleukin-15 (GO:0070672) | 3.05763395 |
| 59 | regulation of RIG-I signaling pathway (GO:0039535) | 3.02981583 |
| 60 | sequestering of actin monomers (GO:0042989) | 3.02869134 |
| 61 | translational termination (GO:0006415) | 3.02504312 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 3.00929032 |
| 63 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.00031145 |
| 64 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.97944369 |
| 65 | negative regulation of B cell apoptotic process (GO:0002903) | 2.96722504 |
| 66 | regulation of response to interferon-gamma (GO:0060330) | 2.93462988 |
| 67 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.90525241 |
| 68 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.90525241 |
| 69 | modulation by symbiont of host immune response (GO:0052553) | 2.90525241 |
| 70 | positive regulation by symbiont of host defense response (GO:0052509) | 2.90525241 |
| 71 | modulation by symbiont of host defense response (GO:0052031) | 2.90525241 |
| 72 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.90525241 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 2.90095467 |
| 74 | regulation of gamma-delta T cell activation (GO:0046643) | 2.88920913 |
| 75 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.88438393 |
| 76 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86505985 |
| 77 | actin nucleation (GO:0045010) | 2.86396957 |
| 78 | leukocyte aggregation (GO:0070486) | 2.85797965 |
| 79 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.85554899 |
| 80 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.85043746 |
| 81 | macrophage activation involved in immune response (GO:0002281) | 2.84834086 |
| 82 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84521684 |
| 83 | negative regulation of innate immune response (GO:0045824) | 2.82637656 |
| 84 | positive regulation of B cell differentiation (GO:0045579) | 2.82027157 |
| 85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80515625 |
| 86 | T cell costimulation (GO:0031295) | 2.80345233 |
| 87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79592698 |
| 88 | ribosomal small subunit biogenesis (GO:0042274) | 2.79347543 |
| 89 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.78367418 |
| 90 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78271084 |
| 91 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.78271084 |
| 92 | lymphocyte costimulation (GO:0031294) | 2.76534883 |
| 93 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.76499592 |
| 94 | cotranslational protein targeting to membrane (GO:0006613) | 2.76151032 |
| 95 | protein targeting to ER (GO:0045047) | 2.75947199 |
| 96 | negative regulation of T cell mediated immunity (GO:0002710) | 2.75661479 |
| 97 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.74538589 |
| 98 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.74379722 |
| 99 | cellular response to interferon-gamma (GO:0071346) | 2.74180849 |
| 100 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.73985584 |
| 101 | regulation of regulatory T cell differentiation (GO:0045589) | 2.73615151 |
| 102 | detection of external biotic stimulus (GO:0098581) | 2.73296425 |
| 103 | leukocyte degranulation (GO:0043299) | 2.71930840 |
| 104 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.70871456 |
| 105 | Peyers patch development (GO:0048541) | 2.70352195 |
| 106 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.70352195 |
| 107 | regulation of B cell apoptotic process (GO:0002902) | 2.68950644 |
| 108 | positive regulation of lymphocyte migration (GO:2000403) | 2.68873566 |
| 109 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.68464448 |
| 110 | translational elongation (GO:0006414) | 2.67519404 |
| 111 | positive regulation of interferon-beta production (GO:0032728) | 2.67500414 |
| 112 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.67279018 |
| 113 | mast cell activation (GO:0045576) | 2.66852828 |
| 114 | regulation of B cell differentiation (GO:0045577) | 2.66250753 |
| 115 | regulation of tolerance induction (GO:0002643) | 2.66132281 |
| 116 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.65658283 |
| 117 | negative thymic T cell selection (GO:0045060) | 2.64232376 |
| 118 | protein localization to endoplasmic reticulum (GO:0070972) | 2.63593836 |
| 119 | dendritic cell differentiation (GO:0097028) | 2.63314643 |
| 120 | lymphocyte chemotaxis (GO:0048247) | 2.62933118 |
| 121 | response to interferon-gamma (GO:0034341) | 2.61951206 |
| 122 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.61648570 |
| 123 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.61488522 |
| 124 | natural killer cell mediated immunity (GO:0002228) | 2.59706976 |
| 125 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.59706976 |
| 126 | neutrophil activation (GO:0042119) | 2.59108275 |
| 127 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.58971552 |
| 128 | negative T cell selection (GO:0043383) | 2.58328656 |
| 129 | regulation of chemokine biosynthetic process (GO:0045073) | 2.57563376 |
| 130 | cellular response to virus (GO:0098586) | 2.57419084 |
| 131 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.57127626 |
| 132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.54654574 |
| 133 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.53733655 |
| 134 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.53317161 |
| 135 | granulocyte activation (GO:0036230) | 2.52803878 |
| 136 | leukocyte mediated cytotoxicity (GO:0001909) | 2.49348295 |
| 137 | myeloid cell activation involved in immune response (GO:0002275) | 2.48282633 |
| 138 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.48070852 |
| 139 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.46644623 |
| 140 | defense response to virus (GO:0051607) | 2.46230686 |
| 141 | B cell receptor signaling pathway (GO:0050853) | 2.45744695 |
| 142 | positive regulation of interleukin-12 production (GO:0032735) | 2.45635042 |
| 143 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.45359361 |
| 144 | natural killer cell activation (GO:0030101) | 2.44913590 |
| 145 | reactive oxygen species biosynthetic process (GO:1903409) | 2.43446084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.81724457 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.44519914 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.16636253 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.98903752 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.94354310 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.93683336 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.90323648 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.87629684 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.79567452 |
| 10 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70338068 |
| 11 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.55612125 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.45315149 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44579761 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38592430 |
| 15 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37086644 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35639174 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.18564256 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15836911 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12579358 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.10865600 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.10668394 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.10615661 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09731312 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.95772282 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95278898 |
| 26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89574422 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.81480103 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79324297 |
| 29 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.78139887 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.76400096 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74731970 |
| 32 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.73995722 |
| 33 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.73624027 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.71742354 |
| 35 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.70240822 |
| 36 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60905386 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60836828 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.60118582 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60031563 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59244689 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.59033932 |
| 42 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56936711 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55946270 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55762352 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.54058639 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.53974947 |
| 47 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53431976 |
| 48 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.52484383 |
| 49 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.50280753 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47700200 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47171631 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.46528380 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46222815 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45852070 |
| 55 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.45690650 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.45085643 |
| 57 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44149436 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43972161 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.40847563 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39101983 |
| 61 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.38295487 |
| 62 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.37637774 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37607936 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36504471 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35940496 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33318585 |
| 67 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.33030656 |
| 68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.31617894 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31199932 |
| 70 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28259091 |
| 71 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.27955127 |
| 72 | * MAF_26560356_Chip-Seq_TH2_Human | 1.27414519 |
| 73 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.26618463 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26523729 |
| 75 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26499919 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23928505 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22321173 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20287004 |
| 79 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19755841 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.17565320 |
| 81 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.17465439 |
| 82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.15742239 |
| 83 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15402088 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13517086 |
| 85 | P68_20966046_ChIP-Seq_HELA_Human | 1.13199424 |
| 86 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13009412 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12783152 |
| 88 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.10126577 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09680911 |
| 90 | P300_27268052_Chip-Seq_Bcells_Human | 1.09448009 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09058203 |
| 92 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07823964 |
| 93 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07648262 |
| 94 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.07283432 |
| 95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06545643 |
| 96 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06204170 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05894892 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04259690 |
| 99 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03420160 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03392194 |
| 101 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02958927 |
| 102 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02911413 |
| 103 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.02829670 |
| 104 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.02791005 |
| 105 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02766415 |
| 106 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02693367 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02674868 |
| 108 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01751178 |
| 109 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01120902 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.00747467 |
| 111 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00318751 |
| 112 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99595024 |
| 113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99486324 |
| 114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98663713 |
| 115 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98257268 |
| 116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.97658349 |
| 117 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.97365066 |
| 118 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.97151866 |
| 119 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96903069 |
| 120 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96808831 |
| 121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96670780 |
| 122 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96203395 |
| 123 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.95832226 |
| 124 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95725852 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95600677 |
| 126 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95291175 |
| 127 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95019654 |
| 128 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.93593524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.89351869 |
| 2 | MP0009785_altered_susceptibility_to | 3.83105505 |
| 3 | MP0005671_abnormal_response_to | 3.56203102 |
| 4 | MP0000685_abnormal_immune_system | 3.52672594 |
| 5 | MP0005025_abnormal_response_to | 3.00852373 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.00539154 |
| 7 | MP0003724_increased_susceptibility_to | 2.94818000 |
| 8 | MP0003436_decreased_susceptibility_to | 2.89938585 |
| 9 | MP0001790_abnormal_immune_system | 2.89404980 |
| 10 | MP0005387_immune_system_phenotype | 2.89404980 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.86558206 |
| 12 | MP0001800_abnormal_humoral_immune | 2.78471386 |
| 13 | MP0006082_CNS_inflammation | 2.66535550 |
| 14 | MP0002723_abnormal_immune_serum | 2.56820417 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.56650367 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.54725551 |
| 17 | MP0002419_abnormal_innate_immunity | 2.51125120 |
| 18 | * MP0001819_abnormal_immune_cell | 2.41799112 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.41203084 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.39253525 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.30916692 |
| 22 | MP0001853_heart_inflammation | 2.19469927 |
| 23 | MP0001873_stomach_inflammation | 2.16524930 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.14659842 |
| 25 | MP0004510_myositis | 2.13646576 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.07386317 |
| 27 | MP0002006_tumorigenesis | 2.06630274 |
| 28 | * MP0002398_abnormal_bone_marrow | 2.00484184 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.96064375 |
| 30 | * MP0000716_abnormal_immune_system | 1.95464810 |
| 31 | MP0002405_respiratory_system_inflammati | 1.93954835 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.90047683 |
| 33 | MP0008469_abnormal_protein_level | 1.78336619 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.71553612 |
| 35 | MP0002722_abnormal_immune_system | 1.67427382 |
| 36 | MP0004947_skin_inflammation | 1.67411883 |
| 37 | * MP0002429_abnormal_blood_cell | 1.66647844 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.66015498 |
| 39 | MP0003303_peritoneal_inflammation | 1.65821699 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.65086746 |
| 41 | MP0005310_abnormal_salivary_gland | 1.56947628 |
| 42 | MP0003866_abnormal_defecation | 1.47225641 |
| 43 | MP0009764_decreased_sensitivity_to | 1.44151237 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.43693701 |
| 45 | MP0003186_abnormal_redox_activity | 1.43466087 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.39210707 |
| 47 | MP0000490_abnormal_crypts_of | 1.35903811 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.33129553 |
| 49 | MP0000858_altered_metastatic_potential | 1.32836626 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.29501670 |
| 51 | MP0009840_abnormal_foam_cell | 1.27714594 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.26630294 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.26630294 |
| 54 | MP0000343_altered_response_to | 1.24768929 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.20029305 |
| 56 | MP0005083_abnormal_biliary_tract | 1.19888798 |
| 57 | MP0002254_reproductive_system_inflammat | 1.18257089 |
| 58 | MP0001666_abnormal_nutrient_absorption | 1.14811329 |
| 59 | MP0003448_altered_tumor_morphology | 1.11642249 |
| 60 | MP0001764_abnormal_homeostasis | 1.07376968 |
| 61 | MP0001663_abnormal_digestive_system | 1.05296751 |
| 62 | MP0009763_increased_sensitivity_to | 1.02736351 |
| 63 | MP0008260_abnormal_autophagy | 1.01887022 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 1.01403072 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.01145327 |
| 66 | MP0005360_urolithiasis | 0.98568299 |
| 67 | MP0003693_abnormal_embryo_hatching | 0.95498113 |
| 68 | MP0003172_abnormal_lysosome_physiology | 0.94229795 |
| 69 | MP0003300_gastrointestinal_ulcer | 0.93353468 |
| 70 | MP0003075_altered_response_to | 0.90502307 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.88529714 |
| 72 | MP0002139_abnormal_hepatobiliary_system | 0.87978214 |
| 73 | MP0002933_joint_inflammation | 0.87751526 |
| 74 | MP0000604_amyloidosis | 0.87179883 |
| 75 | MP0001348_abnormal_lacrimal_gland | 0.86138595 |
| 76 | MP0005166_decreased_susceptibility_to | 0.85916382 |
| 77 | MP0005451_abnormal_body_composition | 0.84772397 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 0.84744867 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 0.83286845 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.82706835 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.82355840 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.82016588 |
| 83 | MP0005365_abnormal_bile_salt | 0.79821855 |
| 84 | MP0002132_abnormal_respiratory_system | 0.78835216 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 0.78128654 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.76611785 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.75205708 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.73276789 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.72643850 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72168680 |
| 91 | MP0000609_abnormal_liver_physiology | 0.70756416 |
| 92 | MP0005390_skeleton_phenotype | 0.70741289 |
| 93 | MP0009278_abnormal_bone_marrow | 0.68758967 |
| 94 | MP0010307_abnormal_tumor_latency | 0.67375804 |
| 95 | MP0002876_abnormal_thyroid_physiology | 0.67010307 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.66782851 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.66587711 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.65888339 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.64646600 |
| 100 | MP0004883_abnormal_blood_vessel | 0.64601307 |
| 101 | MP0001851_eye_inflammation | 0.63735146 |
| 102 | MP0005084_abnormal_gallbladder_morpholo | 0.62801842 |
| 103 | MP0003828_pulmonary_edema | 0.61621345 |
| 104 | MP0000249_abnormal_blood_vessel | 0.61043601 |
| 105 | MP0005085_abnormal_gallbladder_physiolo | 0.60667680 |
| 106 | MP0000598_abnormal_liver_morphology | 0.60624887 |
| 107 | MP0008873_increased_physiological_sensi | 0.59099518 |
| 108 | MP0004381_abnormal_hair_follicle | 0.58483034 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.56945335 |
| 110 | MP0003638_abnormal_response/metabolism_ | 0.56739489 |
| 111 | MP0008874_decreased_physiological_sensi | 0.56461785 |
| 112 | MP0005165_increased_susceptibility_to | 0.56234712 |
| 113 | MP0003045_fibrosis | 0.56044755 |
| 114 | MP0008875_abnormal_xenobiotic_pharmacok | 0.54478531 |
| 115 | MP0003795_abnormal_bone_structure | 0.52180276 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.51212955 |
| 117 | MP0008004_abnormal_stomach_pH | 0.49262929 |
| 118 | MP0005164_abnormal_response_to | 0.49113249 |
| 119 | MP0005535_abnormal_body_temperature | 0.48212473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.30465917 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.88765220 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.73471229 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.46914848 |
| 5 | Chronic otitis media (HP:0000389) | 4.11822475 |
| 6 | Myositis (HP:0100614) | 3.89200202 |
| 7 | Recurrent bronchitis (HP:0002837) | 3.77439903 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.77194984 |
| 9 | Recurrent cutaneous fungal infections (HP:0011370) | 3.69070823 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.69070823 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.58318891 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.54661599 |
| 13 | Recurrent skin infections (HP:0001581) | 3.52856488 |
| 14 | Recurrent viral infections (HP:0004429) | 3.39109258 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.37920693 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.33227759 |
| 17 | Increased IgM level (HP:0003496) | 3.32268159 |
| 18 | IgM deficiency (HP:0002850) | 3.31283448 |
| 19 | Thrombocytosis (HP:0001894) | 3.30102485 |
| 20 | Nasal polyposis (HP:0100582) | 3.16065496 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.15607272 |
| 22 | Abnormality of T cells (HP:0002843) | 3.10363270 |
| 23 | Abnormality of the nasal mucosa (HP:0000433) | 3.10249199 |
| 24 | Petechiae (HP:0000967) | 3.06748130 |
| 25 | Pustule (HP:0200039) | 3.02225368 |
| 26 | Vasculitis (HP:0002633) | 3.01263600 |
| 27 | T lymphocytopenia (HP:0005403) | 3.00388607 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 2.94218834 |
| 29 | Orchitis (HP:0100796) | 2.93026528 |
| 30 | Agammaglobulinemia (HP:0004432) | 2.87478330 |
| 31 | Hypergammaglobulinemia (HP:0010702) | 2.84540230 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.82944768 |
| 33 | Obstructive lung disease (HP:0006536) | 2.82944768 |
| 34 | Meningitis (HP:0001287) | 2.81032381 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.80472852 |
| 36 | Interstitial pulmonary disease (HP:0006530) | 2.78111712 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.74741632 |
| 38 | IgG deficiency (HP:0004315) | 2.72791093 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71025429 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.66390528 |
| 41 | Abnormal number of erythroid precursors (HP:0012131) | 2.65892825 |
| 42 | Basal ganglia calcification (HP:0002135) | 2.64900644 |
| 43 | Gingivitis (HP:0000230) | 2.64225084 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.62639143 |
| 45 | Stomatitis (HP:0010280) | 2.61357384 |
| 46 | Severe combined immunodeficiency (HP:0004430) | 2.61134994 |
| 47 | Urticaria (HP:0001025) | 2.60320469 |
| 48 | Abnormality of the prostate (HP:0008775) | 2.58518793 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.57881041 |
| 50 | Systemic lupus erythematosus (HP:0002725) | 2.57407220 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.55411131 |
| 52 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.55411131 |
| 53 | Abnormality of glycolipid metabolism (HP:0010969) | 2.55411131 |
| 54 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.51793983 |
| 55 | Chronic sinusitis (HP:0011109) | 2.50499882 |
| 56 | Optic neuritis (HP:0100653) | 2.50401647 |
| 57 | Retrobulbar optic neuritis (HP:0100654) | 2.50401647 |
| 58 | Lymphopenia (HP:0001888) | 2.50354146 |
| 59 | Chest pain (HP:0100749) | 2.48877062 |
| 60 | Cellulitis (HP:0100658) | 2.48559699 |
| 61 | Periodontitis (HP:0000704) | 2.46792317 |
| 62 | Panhypogammaglobulinemia (HP:0003139) | 2.45157291 |
| 63 | Recurrent sinusitis (HP:0011108) | 2.42252589 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.39059448 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.37228855 |
| 66 | Hepatosplenomegaly (HP:0001433) | 2.36451537 |
| 67 | Granulocytopenia (HP:0001913) | 2.32812630 |
| 68 | Gastrointestinal inflammation (HP:0004386) | 2.32154278 |
| 69 | Leukocytosis (HP:0001974) | 2.31675115 |
| 70 | Increased cerebral lipofuscin (HP:0011813) | 2.30808896 |
| 71 | Abnormality of eosinophils (HP:0001879) | 2.28820538 |
| 72 | Abnormality of the pleura (HP:0002103) | 2.26827532 |
| 73 | Chronic diarrhea (HP:0002028) | 2.26421256 |
| 74 | Spontaneous hematomas (HP:0007420) | 2.26151334 |
| 75 | Purpura (HP:0000979) | 2.25966991 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.25789902 |
| 77 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.25777777 |
| 78 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.25777777 |
| 79 | Hemoptysis (HP:0002105) | 2.25617769 |
| 80 | Eosinophilia (HP:0001880) | 2.23732668 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.23515066 |
| 82 | Reticulocytopenia (HP:0001896) | 2.23347753 |
| 83 | Hypoplasia of the thymus (HP:0000778) | 2.22653387 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 2.21220303 |
| 85 | Thyroiditis (HP:0100646) | 2.20470232 |
| 86 | Hypertensive crisis (HP:0100735) | 2.18081940 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.17410704 |
| 88 | Sepsis (HP:0100806) | 2.17206875 |
| 89 | Increased serum ferritin (HP:0003281) | 2.16970138 |
| 90 | Gingival bleeding (HP:0000225) | 2.16431764 |
| 91 | Hepatic necrosis (HP:0002605) | 2.15914457 |
| 92 | Epistaxis (HP:0000421) | 2.13124590 |
| 93 | Hepatocellular necrosis (HP:0001404) | 2.12750467 |
| 94 | Joint swelling (HP:0001386) | 2.11499629 |
| 95 | Pallor (HP:0000980) | 2.09661443 |
| 96 | Recurrent pneumonia (HP:0006532) | 2.09131915 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.08176313 |
| 98 | Colitis (HP:0002583) | 2.07373671 |
| 99 | Encephalitis (HP:0002383) | 2.07298878 |
| 100 | Bronchitis (HP:0012387) | 2.06949942 |
| 101 | Mitochondrial inheritance (HP:0001427) | 2.06808684 |
| 102 | Increased IgE level (HP:0003212) | 2.05349697 |
| 103 | Skin ulcer (HP:0200042) | 2.04638097 |
| 104 | Skin rash (HP:0000988) | 2.03851990 |
| 105 | Gangrene (HP:0100758) | 2.03625322 |
| 106 | Anorexia (HP:0002039) | 2.03492542 |
| 107 | Acute hepatic failure (HP:0006554) | 2.03320946 |
| 108 | Recurrent lower respiratory tract infections (HP:0002783) | 2.03083177 |
| 109 | Verrucae (HP:0200043) | 2.02241396 |
| 110 | Papilloma (HP:0012740) | 2.02241396 |
| 111 | Increased muscle lipid content (HP:0009058) | 2.01301669 |
| 112 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.00037457 |
| 113 | Osteomyelitis (HP:0002754) | 1.99674879 |
| 114 | B lymphocytopenia (HP:0010976) | 1.99394743 |
| 115 | Abnormality of B cell number (HP:0010975) | 1.99394743 |
| 116 | Keratoconjunctivitis (HP:0001096) | 1.98581994 |
| 117 | Neutropenia (HP:0001875) | 1.98093990 |
| 118 | Increased intramyocellular lipid droplets (HP:0012240) | 1.96465027 |
| 119 | Microcytic anemia (HP:0001935) | 1.95483090 |
| 120 | Nausea (HP:0002018) | 1.94355470 |
| 121 | Aplastic anemia (HP:0001915) | 1.93003879 |
| 122 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.92414347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.87891818 |
| 2 | TBK1 | 3.41810153 |
| 3 | TYK2 | 3.08709100 |
| 4 | BLK | 3.07202419 |
| 5 | IKBKE | 3.01794714 |
| 6 | MAP3K14 | 2.96169736 |
| 7 | NME2 | 2.93923097 |
| 8 | TXK | 2.72295060 |
| 9 | ERN1 | 2.69754822 |
| 10 | VRK2 | 2.61775473 |
| 11 | KIT | 2.59254026 |
| 12 | JAK3 | 2.42371459 |
| 13 | IRAK4 | 2.39443187 |
| 14 | ZAP70 | 2.27989664 |
| 15 | KDR | 2.20442523 |
| 16 | PIM2 | 2.15926366 |
| 17 | IRAK3 | 1.86843012 |
| 18 | IKBKB | 1.84516996 |
| 19 | EIF2AK1 | 1.80288631 |
| 20 | SYK | 1.77750009 |
| 21 | TEC | 1.77297505 |
| 22 | BTK | 1.69965448 |
| 23 | MST4 | 1.66132932 |
| 24 | FGFR4 | 1.65941412 |
| 25 | RIPK4 | 1.64198966 |
| 26 | JAK1 | 1.56413174 |
| 27 | MAP3K12 | 1.48360387 |
| 28 | GRK6 | 1.46177486 |
| 29 | BCKDK | 1.39109383 |
| 30 | STK16 | 1.32581585 |
| 31 | MAP3K13 | 1.31529057 |
| 32 | FLT3 | 1.30258627 |
| 33 | LCK | 1.17420035 |
| 34 | LYN | 1.16488666 |
| 35 | EIF2AK3 | 1.16439549 |
| 36 | CSF1R | 1.14219830 |
| 37 | RPS6KA4 | 1.09873476 |
| 38 | PRPF4B | 1.06620674 |
| 39 | CSK | 1.05720152 |
| 40 | GRK7 | 1.01085597 |
| 41 | MAP2K3 | 1.00894479 |
| 42 | TAOK2 | 1.00430073 |
| 43 | MAP3K11 | 0.99527618 |
| 44 | PBK | 0.99178577 |
| 45 | TGFBR1 | 0.98175653 |
| 46 | MYLK | 0.98086568 |
| 47 | NME1 | 0.97558576 |
| 48 | TAOK3 | 0.95897278 |
| 49 | NEK9 | 0.95752494 |
| 50 | ARAF | 0.95594813 |
| 51 | TESK2 | 0.94460027 |
| 52 | SMG1 | 0.91391648 |
| 53 | PIM1 | 0.90432387 |
| 54 | NLK | 0.88018148 |
| 55 | SCYL2 | 0.87593143 |
| 56 | ITK | 0.86425381 |
| 57 | LRRK2 | 0.86157570 |
| 58 | HCK | 0.85488107 |
| 59 | STK10 | 0.82275821 |
| 60 | CHUK | 0.80323010 |
| 61 | MST1R | 0.78377088 |
| 62 | FES | 0.77238725 |
| 63 | TGFBR2 | 0.74120766 |
| 64 | MATK | 0.73195263 |
| 65 | VRK1 | 0.73062625 |
| 66 | MARK3 | 0.71377359 |
| 67 | JAK2 | 0.69950483 |
| 68 | MAP2K6 | 0.69404108 |
| 69 | PIK3CG | 0.68496925 |
| 70 | ZAK | 0.67497574 |
| 71 | FGR | 0.67313118 |
| 72 | MAP3K1 | 0.67052768 |
| 73 | TAOK1 | 0.66387089 |
| 74 | CDK19 | 0.64575987 |
| 75 | BUB1 | 0.62384145 |
| 76 | NUAK1 | 0.61722278 |
| 77 | ABL2 | 0.61639230 |
| 78 | PKN2 | 0.60950333 |
| 79 | FGFR3 | 0.60057553 |
| 80 | TESK1 | 0.57776643 |
| 81 | MAP2K2 | 0.57663703 |
| 82 | ADRBK2 | 0.57212719 |
| 83 | ACVR1B | 0.57111095 |
| 84 | PRKCD | 0.54778284 |
| 85 | HIPK2 | 0.54705801 |
| 86 | EIF2AK2 | 0.53095562 |
| 87 | STK4 | 0.50227492 |
| 88 | PRKG2 | 0.50021351 |
| 89 | DAPK3 | 0.49562485 |
| 90 | TAF1 | 0.48665077 |
| 91 | PDK1 | 0.46698979 |
| 92 | DAPK1 | 0.44910102 |
| 93 | TLK1 | 0.44352776 |
| 94 | MAP3K10 | 0.43107690 |
| 95 | TIE1 | 0.42921886 |
| 96 | PRKCQ | 0.42368229 |
| 97 | CDK4 | 0.42268256 |
| 98 | MAPK11 | 0.42192217 |
| 99 | FYN | 0.41864662 |
| 100 | EPHB1 | 0.41803042 |
| 101 | MAPK12 | 0.40332504 |
| 102 | GRK5 | 0.39587404 |
| 103 | ILK | 0.38897552 |
| 104 | RPS6KB2 | 0.38511740 |
| 105 | RPS6KA6 | 0.38242197 |
| 106 | BMPR2 | 0.37342477 |
| 107 | TSSK6 | 0.36682775 |
| 108 | MAPKAPK3 | 0.36094637 |
| 109 | MAPK4 | 0.36041639 |
| 110 | RAF1 | 0.35560361 |
| 111 | MAP3K3 | 0.34393155 |
| 112 | MAP3K5 | 0.33996293 |
| 113 | MAP3K8 | 0.33462793 |
| 114 | TNK2 | 0.33018935 |
| 115 | EPHA3 | 0.33018825 |
| 116 | MAPKAPK2 | 0.32994789 |
| 117 | RPS6KA5 | 0.31900840 |
| 118 | SIK3 | 0.31370335 |
| 119 | IRAK1 | 0.30803089 |
| 120 | LIMK1 | 0.27882183 |
| 121 | RPS6KC1 | 0.27743516 |
| 122 | RPS6KL1 | 0.27743516 |
| 123 | ABL1 | 0.25717430 |
| 124 | PAK1 | 0.25605519 |
| 125 | PDPK1 | 0.24706948 |
| 126 | MAPK7 | 0.19816223 |
| 127 | MAPK3 | 0.19426157 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.23763960 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.14530505 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 3.02105874 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.61049239 |
| 5 | * Proteasome_Homo sapiens_hsa03050 | 2.60104429 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.58978914 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.51330087 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.43062380 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.39301188 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.28414446 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.22417711 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.15584187 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 2.01159302 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.96125089 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94066784 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.93411211 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83102583 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.71587297 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69642672 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.64974101 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.64100845 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.57347176 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52323627 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.50782945 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49785424 |
| 26 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.48919480 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41429105 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.29633469 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.29418691 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.27436464 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26560532 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22556401 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.22530702 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.22472462 |
| 35 | Mismatch repair_Homo sapiens_hsa03430 | 1.22073867 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16253276 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.13354879 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12962885 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 1.12909219 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12749945 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.11772079 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10276635 |
| 43 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10002980 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09692563 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08560722 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.07690679 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.07434928 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06053137 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04752376 |
| 50 | RNA polymerase_Homo sapiens_hsa03020 | 1.02059688 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.01390691 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00097682 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 0.98772185 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96154814 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94260545 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93588038 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91578571 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89911658 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88201059 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84614574 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.79306720 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77859094 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76260077 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.76186096 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.75396552 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 0.75366974 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74237327 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68824940 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67252954 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66070709 |
| 71 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.65507180 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62844591 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61713199 |
| 74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60304360 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.58303245 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57931593 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57307540 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.56815995 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55750551 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55457441 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53215888 |
| 82 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52196398 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51810986 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51418842 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50763819 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.47510082 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46395711 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45295052 |
| 89 | Spliceosome_Homo sapiens_hsa03040 | 0.45091483 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43371790 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.41750585 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40576564 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38011944 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37813540 |
| 95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36554244 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36473411 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.35868840 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34489685 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.33874603 |
| 100 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.32717741 |
| 101 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31967460 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31918233 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30537172 |
| 104 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.30502501 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30410005 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29725250 |
| 107 | Carbon metabolism_Homo sapiens_hsa01200 | 0.29265968 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29201346 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28396164 |
| 110 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26131616 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26043627 |
| 112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25479215 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.23597477 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19326944 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.19083846 |
| 116 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.18303035 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.13301056 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.12251893 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10296795 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.09600502 |

